NSE filing, NSE: VITAL. Summary written from the filing by ALFA Finder's alert engine.
Vital Chemtech Ltd: key numbers
- Share price
- ₹49.95
- Market cap
- ₹119.6 Cr
- Revenue (annual)
- ₹126.7 Cr
- Net profit (annual)
- ₹1.03 Cr
- P/E (TTM)
- 81.2×Sector 34.1×
- Promoter holding
- 73.43%+0.00% QoQ
- FII holding
- 1.62%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vital Chemtech Ltd
All →Vital Chemtech Management Change
Vital Chemtech Limited has re-appointed Vipul Bhatt as Managing Director and Jay Bhatt as Whole Time Director for 60 months. The company also ratified SCS & Co. LLP as Secretarial Auditor.
- Execution
- 60 months
Vital Chemtech Annual General Meeting
Vital Chemtech Limited successfully concluded its 5th Annual General Meeting on September 28, 2026, via video conferencing, conducting all agenda items as scheduled.
Vital Chemtech Other Announcement
Vital Chemtech Limited has intimated the Exchange regarding the dispatch of a web-link for its Integrated Annual Report 2025-26 to shareholders with unregistered email addresses.
Vital Chemtech Annual General Meeting
Vital Chemtech Limited will hold its 5th Annual General Meeting on September 28, 2026, via video conferencing. The meeting agenda includes financial statement adoption and director re-appointments.
Vital Chemtech Management Change
Vital Chemtech Limited appointed Mr. Jitendra Raval as Chief Financial Officer, succeeding Mr. Vipul Bhatt who resigned effective August 14, 2026.
Vital Chemtech Q1 FY27 Results: Net Profit ₹2.6 Cr, Up 160.0% YoY
Vital Chemtech Ltd reported revenue from operations of ₹51.2 Cr (+51.5% YoY) and net profit of ₹2.6 Cr (+160.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2.6 Cr · +160.0% YoY
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.